SE7607331L - Pyrrolidoner och forfarande for deras framstellning - Google Patents

Pyrrolidoner och forfarande for deras framstellning

Info

Publication number
SE7607331L
SE7607331L SE7607331A SE7607331A SE7607331L SE 7607331 L SE7607331 L SE 7607331L SE 7607331 A SE7607331 A SE 7607331A SE 7607331 A SE7607331 A SE 7607331A SE 7607331 L SE7607331 L SE 7607331L
Authority
SE
Sweden
Prior art keywords
pyrrolidones
procedures
preparation
Prior art date
Application number
SE7607331A
Other languages
English (en)
Inventor
W Bartmann
R Kunstmann
U Lerch
B Scholkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7607331L publication Critical patent/SE7607331L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7607331A 1975-06-27 1976-06-24 Pyrrolidoner och forfarande for deras framstellning SE7607331L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7607331L true SE7607331L (sv) 1976-12-28

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607331A SE7607331L (sv) 1975-06-27 1976-06-24 Pyrrolidoner och forfarande for deras framstellning

Country Status (14)

Country Link
JP (1) JPS525764A (sv)
AT (1) AT365575B (sv)
BE (1) BE843505A (sv)
CH (1) CH623809A5 (sv)
DE (1) DE2528664A1 (sv)
DK (1) DK287476A (sv)
ES (1) ES449095A1 (sv)
FR (1) FR2316943A1 (sv)
GB (1) GB1553595A (sv)
IL (1) IL49916A0 (sv)
LU (1) LU75235A1 (sv)
NL (1) NL7606773A (sv)
SE (1) SE7607331L (sv)
ZA (1) ZA763802B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1077948A (en) * 1976-08-06 1980-05-20 Albin J. Nelson 1,-5 disubstituted-2-pyrrolidones and processes for their production
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
AP2002002555A0 (en) * 1999-12-22 2002-06-30 Pfizer Prod Inc EP4 Receptor selective agonists in the treatment of osteoporosis.
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
IL155368A0 (en) 2000-11-27 2003-11-23 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis
AU2002328855B2 (en) 2001-07-16 2005-11-24 F. Hoffmann-La Roche Ag Prostaglandin Analogues As EP4 Receptor Agonists
JP4211605B2 (ja) 2001-07-16 2009-01-21 小野薬品工業株式会社 プロスタノイドアゴニストとしての2ピロリドン誘導体
US7608637B2 (en) 2001-07-23 2009-10-27 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient
DE60307607T2 (de) * 2002-03-18 2007-08-09 Pfizer Products Inc., Groton Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1585729A1 (en) 2003-01-10 2005-10-19 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
EP3176162B1 (en) 2012-07-19 2020-05-27 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
ES2635635T3 (es) 2013-03-15 2017-10-04 Cayman Chemical Company, Incorporated Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
WO2014144610A1 (en) * 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
US9914725B2 (en) 2013-03-15 2018-03-13 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Also Published As

Publication number Publication date
LU75235A1 (sv) 1977-03-16
IL49916A0 (en) 1976-08-31
AT365575B (de) 1982-01-25
CH623809A5 (en) 1981-06-30
ZA763802B (en) 1977-05-25
GB1553595A (en) 1979-09-26
ATA467976A (de) 1981-06-15
BE843505A (fr) 1976-12-28
FR2316943B1 (sv) 1978-11-03
DE2528664A1 (de) 1977-01-13
NL7606773A (nl) 1976-12-29
ES449095A1 (es) 1977-12-16
DK287476A (da) 1976-12-28
JPS525764A (en) 1977-01-17
FR2316943A1 (fr) 1977-02-04

Similar Documents

Publication Publication Date Title
SE7803660L (sv) Cefemderivat och forfarande for deras framstellning
SE7804185L (sv) Cefemderivat och forfarande for deras framstellning
SE7614218L (sv) Basiskt substituerade indolderivat och forfarande for deras framstellning
SE7802853L (sv) Cefemderivat och forfarande for deras framstellning
SE7607331L (sv) Pyrrolidoner och forfarande for deras framstellning
SE429236B (sv) Alkoxisilanolklusterforeningar och forfarande for deras framstellning
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
SE7709333L (sv) Dihydro-oxo-nikotinsyror och forfarande for deras framstellning
SE7610630L (sv) Hypolipemiska foreningar och forfarande for deras framstellning
SE7512354L (sv) Pyrrolidoner och forfarande for deras framstellning
SE426166B (sv) Fortjockad och tverbunden vattenhaltig skumsprengemneskomposition
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE7613947L (sv) Sekunder eteraminer och forfarande for deras framstellning
SE7607241L (sv) Aralifatiska dihalogenforeningar och forfarande for framstellning derav
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
SE7607330L (sv) Pyrrolidoner och forfarande for deras framstellning
SE7514113L (sv) 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler och forfarande for deras framstellning
SE7613948L (sv) Nya pyrrolidoner och forfarande for deras framstellning
SE432424B (sv) Halogenerade alkoxisilanforeningar och forfarande for deras framstellning
SE7606071L (sv) Aromkomposition och forfarande for framstellning derav
SE7614386L (sv) Bensamider och forfarande for framstellning derav
SE7600704L (sv) Difenyleter-derivat och forfarande for framstellning derav
SE7601068L (sv) Vermeaterhemtbara foremal och forfarande for deras framstellning
SE7805874L (sv) 1-fenyl-1-metoxi-2-amino-etanderivat och forfarande for framstellning derav